mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |